Medicare Enrolled

Dr. Ian Vandergulik, DPM

Foot & Ankle Surgery Podiatrist · San Antonio, TX
Research-focused
5282 MEDICAL DR STE 260, San Antonio, TX 78229
2109707802
In practice since 2020 (5 years)
NPI: 1033733852 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vandergulik from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vandergulik? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vandergulik

Dr. Ian Vandergulik is a foot & ankle surgery podiatrist in San Antonio, TX, with 5 years of NPI registration.

Between the years covered by Open Payments, Dr. Vandergulik received a total of $24,914 from 17 pharmaceutical and/or device companies across 105 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in foot & ankle surgery podiatrist. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vandergulik is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 5 years in practice $24,914 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$24,914
Total received (2020-2024)
Avg $4,983/year across 5 years
Top 8% in TX for foot & ankle surgery podiatrist
17
Companies
105
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Scientific / Research
Research funding and grants
$10,000 (40.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,710 (35.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,205 (24.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$11,346
2023
$5,143
2022
$4,579
2021
$2,570
2020
$1,276

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Arthrex, Inc.
$10,000
Supreme Orthopedic Systems, LLC
$6,205
Orthofix Medical, Inc.
$3,232
Medical Device Business Services, Inc.
$2,161
DePuy Synthes Sales Inc.
$745
TREACE MEDICAL CONCEPTS, INC.
$642
Stryker Corporation
$511
Smith+Nephew, Inc.
$281
Mission Medical Distribution, LLC
$276
Bioventus LLC
$206
Sanara MedTech Inc.
$192
NuVasive Specialized Orthopedics, Inc.
$164
Janssen Pharmaceuticals, Inc
$125
Bone Support Inc.
$90
Paragon 28, Inc.
$49
Philips North America LLC
$24
Integra LifeSciences Corporation
$12
Top 3 companies account for 78.0% of total payments
Associated products mentioned in payments ›
(5153) Azurion 5 M20 GC · ANCHORAGE · CERAMENTBONE VOID FILLER · CellerateRx · EXOGEN ULTRASOUND BONE HEALING SYSTEM · FIBERGRAFT Aeridyan Matrix · FIBULINK · GRAFIX PL · INFINITY · LAPIPLASTY SYSTEM · NA · PRECICE Intramedullary Limb Lengthening System · PRODUCT PORTFOLIO · PROSTEP · Pico 14 · TENOGLIDE TENDON PROTECTOR SHEET · TrueLok · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (40%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work. Total industry engagement is in the top 8% for foot & ankle surgery podiatrist in TX.

Looking for a foot & ankle surgery podiatrist in San Antonio?
Compare foot & ankle surgery podiatrists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse foot & ankle surgery podiatrists nearby

Geographic Context

Foot & ankle surgery podiatrists within 10 mi
70
Per 100K population
3.4
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Vandergulik is a foot & ankle surgery podiatrist, with research-focused industry engagement in the top 8% of TX peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Vandergulik receive payments from pharmaceutical companies?
Yes. Dr. Vandergulik received a total of $24,914 from 17 companies across 105 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Vandergulik) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →